You are here » Home » Companies » Company Overview » Glenmark Pharmaceuticals Ltd

Glenmark Pharmaceuticals Ltd.

BSE: 532296 Sector: Health care
NSE: GLENMARK ISIN Code: INE935A01035
BSE 15:49 | 23 Feb 533.80 9.40
(1.79%)
OPEN

521.15

HIGH

536.50

LOW

521.15

NSE 15:58 | 23 Feb 534.30 10.75
(2.05%)
OPEN

525.00

HIGH

536.65

LOW

524.95

OPEN 521.15
PREVIOUS CLOSE 524.40
VOLUME 52204
52-Week high 957.50
52-Week low 517.40
P/E 11.82
Mkt Cap.(Rs cr) 15,064
Buy Price 0.00
Buy Qty 0.00
Sell Price 533.80
Sell Qty 130.00
OPEN 521.15
CLOSE 524.40
VOLUME 52204
52-Week high 957.50
52-Week low 517.40
P/E 11.82
Mkt Cap.(Rs cr) 15,064
Buy Price 0.00
Buy Qty 0.00
Sell Price 533.80
Sell Qty 130.00

Glenmark Pharmaceuticals Ltd. (GLENMARK) - Company Information

Glenmark Pharmaceuticals Ltd

COMPANY INFORMATION
Chairman & Managing Director : Glenn Saldanha
Director : Julio F Ribeiro
Director : Sridhar Gorthi
Director (Corporate Affairs) : Cheryl Pinto
Director : D R Mehta
Non Executive Director : B E Saldanha
Non Executive Director : Rajesh Desai
Director : Brian W Tempest
Director : Bernard Munos
Director : Milind Sarwate
Company Secretary : Harish Kuber
Executive Director : Murali Neelakantan
AUDITOR : Walker Chandiok & Co LLP
IND NAME : Pharmaceuticals - Indian - Bulk Drugs & Formln
HOUSE NAME : Indian Private
Registered office
B/2 Mahalaxmi Chambers, 22 Bhulabhai Desai Road,Mumbai,Maharashtra-400026
Ph : 91-22-40189999
WEBSITE : http://www.glenmarkpharma.com
E-mail : complianceofficer@glenmarkpharma.com